Background Stroke after transcatheter aortic valve implantation (TAVI) is an infrequent but serious complication with ...

PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...

The TAVR is a real, true, bona fide miracle of modern medicine. And it isn’t simple at all.

Seven-year follow-up data show that transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement have ...

A P rospective rA ndomized tR ial A ssessing the safety and effectiveness of the D urAVR® bI omimetic valve designed for physioloG ic ...

The Central Chest Institute of Thailand (CCIT) in Nonthaburi has adopted the Tavi procedure to treat aortic valve stenosis, a ...

Edwards Lifesciences has raised its fiscal year (FY25) guidance to between $2.56 to $2.62 per share after achieving better ...

He is trading hospital gowns for a suit as he steps back on stage after a health scare that nearly stopped the show.

A troubling rise in severe diverticulitis cases among Americans under 50 highlights a significant public health concern.

Jenscare Scientific Co., Ltd. (Jenscare or the Company) (HKEX: 9877), an innovative medical device company, recently released 6-month follow-up results of TRINITY Trial of LuX-Valve Plus, a promising ...